8-K/A

FORM 8-K AMENDMENT NO. 1

Company: BIOCRYST PHARMACEUTICALS INC
Filed: August 4, 2011
Period of Report: August 4, 2011
Accession Number: 0001193125-11-209915

View Document ↗ View on SEC.gov ↗